Vaginal discharge during menopause

Key takeaways

• Vaginal discharge often becomes lighter, thinner, or more watery during perimenopause and postmenopause due falling oestrogen levels affecting the vaginal environment.
• Some changes in colour or consistency warrant a GP or specialist assessment, particularly yellow or green discharge, brown spotting, or any unexpected bleeding after menopause.
• Vaginal oestrogen, which NICE recommends as a first-line option is an effective treatment for the underlying hormonal changes driving most discharge-related symptoms, including

Vaginal discharge is not something most women talk about openly but changes to discharge are among the most common physical shifts of this life stage, and the questions women type into search engines at midnight suggest that a lot of them are worried. The good news is that most changes are completely normal, and those that are not are usually straightforward to assess and treat. This guide explains what happens to vaginal discharge in perimenopause and postmenopause, what different colours and consistencies can indicate, and what treatment options are available if something is causing you discomfort or concern.

What is vaginal discharge, and how does menopause change it?

Vaginal discharge is a normal part of how the vagina maintains itself. Secretions produced by the cervix and vaginal walls keep the vaginal environment healthy, remove dead cells, and protect against infection.

During the reproductive years, discharge fluctuates throughout the menstrual cycle in response to hormonal changes. As menopause approaches, oestrogen levels fluctuate and decline, and this changes the vaginal environment in several important ways.

Oestrogen plays a central role in maintaining the thickness and elasticity of vaginal tissue, supporting a healthy vaginal pH (typically between 3.8 and 4.5), and sustaining the population of Lactobacillus bacteria that protect against infection. As oestrogen falls, vaginal tissue thins and becomes less well-lubricated, vaginal pH rises (often above 5.0), and Lactobacillus levels decline. The result is a vaginal environment that produces less discharge, is more prone to dryness, and is more susceptible to bacterial imbalance and infection.

This cluster of changes has a formal clinical name: genitourinary syndrome of menopause (GSM). GSM is the internationally accepted term for the full range of genital, urinary, and sexual symptoms caused by reduced oestrogen in this area as a result of menopause. Between 27% and 84% of postmenopausal women experience GSM symptoms, with vaginal dryness being the most commonly reported, affecting around 60% of women in the postmenopausal period.

Perimenopause vs postmenopause: why discharge patterns differ

It is worth distinguishing between perimenopause (the stage leading up to menopause) and postmenopause (the stage after 12 consecutive months without a period), because discharge patterns are different at each stage.

During perimenopause, oestrogen levels fluctuate rather than decline steadily. This means discharge can be unpredictable: heavier in some months, lighter in others, with changes in consistency that mirror the hormonal ups and downs of irregular cycles. Some women notice more discharge during this phase; others notice less. Spotting between periods is also common and is usually related to hormonal fluctuation rather than anything sinister, though it always warrants assessment if it is unexpected.

After menopause, without the cyclical hormonal fluctuations, discharge typically becomes lighter, thinner, and less frequent. Some women notice very little discharge at all. This is a direct result of reduced oestrogen stimulation of the vaginal and cervical glands.

What normal discharge looks like during perimenopause

There is no single definition of "normal" discharge during perimenopause, because it varies from person to person and across the stages of the transition. As a general guide, normal perimenopausal discharge tends to be:

• Clear, white, or very pale in colour
• Thin, watery, or slightly milky in consistency
• Lighter in volume than it was during the reproductive years (healthy discharge during the reproductive years is typically around 1 to 5ml over 24 hours; this often decreases further with menopause)
• Without a strong or unpleasant odour

It is also entirely normal to have very little discharge at all, particularly once in postmenopause. A reduction in discharge is not a problem unless it is accompanied by symptoms of dryness, irritation, or discomfort.

If discharge falls within these parameters and is not causing discomfort, there is usually no cause for concern. If something feels different, has changed noticeably, or is accompanied by itching, burning, or odour, further assessment is indicated.

Discharge colour guide: what each colour can mean

The colour and consistency of discharge is one of the most useful indicators of what is happening in the vaginal environment. This is not a diagnostic tool, but it is a helpful starting point.

Clear or white. Clear or white discharge that is odourless or very mildly scented is healthy. Thin, watery discharge is also fine and reflects the changing vaginal environment.

Yellow or pale yellow. A small amount of very pale yellow discharge can sometimes be normal, particularly if it has no odour and causes no symptoms. Brighter yellow discharge, especially if it has an unusual smell or is accompanied by itching or irritation, can indicate bacterial vaginosis (BV) or another infection. BV is more common after menopause because the rise in vaginal pH creates conditions where protective Lactobacillus bacteria are depleted allowing other bacteria to overgrow.

Green. Green discharge is not considered normal at any stage of life and usually indicates infection, most commonly BV, a sexually transmitted infection (STI), or another bacterial infection. Please arrange to see your GP or a specialist.

Brown. Here context matters. Brown discharge in perimenopause is often old blood from irregular cycles and is usually not a cause for concern. Brown discharge or spotting after menopause (more than 12 months since your last period) is less straightforward and should always be assessed by a clinician, especially if you are not on HRT. Brown discharge can be due to benign causes such as vaginal dryness or small tears in thinning vaginal tissue, but it can also indicate changes in the womb lining that need investigation.

Pink or blood-tinged. Pink or lightly blood-tinged discharge in postmenopause should not be ignored if you are not on HRT. While it can result from friction or minor irritation of thinned vaginal tissue, it can also be an early sign of endometrial or cervical changes. The section below on bleeding covers the referral guidance in more detail as it depends on whether you are on HRT or not and what your risk factors are.

Grey. Grey discharge with a fishy odour is a classic indicator of bacterial vaginosis. BV is particularly common after menopause and is often mistaken for normal vaginal changes or for thrush. It is treatable with topical antibiotics.

Genitourinary syndrome of menopause (GSM): when discharge is a sign of something treatable

GSM is not a rare or unusual condition. Research published in Frontiers in Reproductive Health estimates that between 27% and 84% of postmenopausal women experience GSM symptoms. It is caused by the decline in oestrogen and it affects the vulva, vagina, and urinary tract.

Symptoms include:

• Vaginal dryness and reduced lubrication
• Altered discharge (lighter, thinner, or occasionally more watery)
• Vaginal itching, burning, or irritation
• Discomfort or pain during sex
• Urinary symptoms such as urgency, frequency, or recurrent infections

The reason GSM matters in the context of discharge is that many of the discharge changes women notice during the menopause transition, including reduced volume, altered consistency, and increased susceptibility to infection, are directly caused by the tissue and pH changes that define GSM.

Crucially, GSM is treatable. NICE guidelines (NG23) recommend treatment for women with urogenital symptoms, and the BMS Consensus Statement on GSM (2025) identifies vaginal oestrogen as the preferred first-line treatment. Unlike systemic HRT, vaginal oestrogen acts locally and is considered appropriate for most women, including many with a history of oestrogen-sensitive conditions such as breast cancer (though individual assessment is always required).

Bacterial vaginosis and thrush: infections that are more common after menopause

Two infections are worth understanding in the context of menopause: bacterial vaginosis (BV) and thrush (a yeast infection). Both become more common after menopause, and both can affect discharge.

Bacterial vaginosis

BV occurs when the natural balance of bacteria in the vagina is disrupted. As oestrogen declines and vaginal pH rises, Lactobacillus bacteria (which maintain a protective acidic environment) reduce in numbers making way for other bacteria to overgrow. Research published in Menopause (2020) highlights a clinically important complication: the diagnostic features of BV (low Lactobacillus, elevated pH above 5) overlap significantly with those of GSM itself, making the two difficult to distinguish without a proper assessment. This is one reason why self-diagnosing and self-treating discharge changes after menopause is not recommended.

BV typically produces grey or yellow discharge with a noticeable fishy odour, often more apparent after sex. It is not a sexually transmitted infection, but it is treated with topical antibiotics (usually metronidazole, but also clindamycin).

Thrush

Thrush (caused by yeast overgrowth) produces thick, white, cottage-cheese-like discharge, usually without odour, and is typically accompanied by intense itching and vulval irritation. It is treated with antifungal creams or tablets. Thrush can sometimes be triggered by antibiotic treatment for an un-related illness such as a chest infection, as well as prolonged treatment for thrush. If you are unsure which (if either) infection you have, a GP or specialist assessment is the right first step. Using over-the-counter treatments without a confirmed diagnosis risks treating the wrong condition and potentially making matters worse.

Postmenopausal bleeding: when to seek urgent help

It is important to distinguish between vaginal discharge and vaginal bleeding, because they have different clinical implications.

Discharge is fluid produced by the vaginal and cervical glands. Bleeding involves blood, either as a visible flow or as blood-tinged or brown discharge originating from the uterus.

Any bleeding that occurs more than 12 months after your last period in a woman not on HRT is considered postmenopausal bleeding and should be assessed promptly by a clinician. This applies whether it is a small amount of spotting, brown discharge, or heavier bleeding.

Most postmenopausal bleeding has a benign cause, including vaginal atrophy, polyps, or fibroids. However, it can also be an early sign of endometrial cancer, which is why assessment is important and timely. NICE guidance (NG12) recommends that women with unexplained postmenopausal bleeding are referred via a suspected cancer pathway for urgent assessment. This is a clinical standard, not a reason to panic. Early investigation is the best protection, and the majority of women referred this way receive reassuring results.

If you are on HRT and experience unexpected bleeding, this also warrants assessment, as it can sometimes indicate that your HRT formulation needs adjusting.

“The discharge changes and symptoms described in this article are not something you simply have to manage. Effective treatments exist, and for most women the right approach makes a significant difference to symptoms and quality of life.”

Katy Jackson, Clinical Director - Women's Health

What can actually help: treatments for vaginal changes in menopause

Vaginal oestrogen

Vaginal oestrogen is the most widely recommended treatment for the vaginal and urinary symptoms of GSM. It is available as a cream, pessary, ring, or tablet inserted directly into the vagina, where it acts locally to restore vaginal tissue thickness, lower vaginal pH, and support healthy Lactobacillus populations. A 2024 systematic review in the Annals of Internal Medicine, which analysed 46 randomised controlled trials, found vaginal oestrogen and other hormonal therapies to be effective for GSM symptom relief. NICE NG23 recommends vaginal oestrogen for women with urogenital symptoms and states that treatment should continue for as long as it is needed. Unlike systemic HRT, vaginal oestrogen remains in the local tissues and is considered appropriate for most women.

Systemic HRT

For women experiencing a broader range of menopause symptoms alongside vaginal changes, systemic HRT can improve vaginal health as part of its wider hormonal effects, though for women whose primary concern is vaginal or urinary symptoms or whose symptoms remain unresolved with systemic HRT, additional vaginal oestrogen preparations are often needed. If you have questions about HRT safety and your individual history, a specialist consultation is the right place to explore them properly.

Vaginal moisturisers and lubricants

Non-hormonal options include vaginal moisturisers (used regularly to maintain vaginal hydration) and lubricants (used during intimacy to reduce friction and discomfort). The BMS Consensus Statement (2025) includes these as part of the management approach for GSM and they can easily be used alongside other hormonal treatments. However, please check with your specialist first, as some of these can affect the patency of condoms.

Lifestyle factors

The BMS Consensus Statement (2025) notes that smoking accelerates oestrogen metabolism and may worsen GSM symptoms, and that regular sexual activity can help maintain vaginal elasticity. These are not replacements for treatment, but they are worth keeping in mind.

When to speak to a specialist, and what that conversation looks like

If changes to your vaginal discharge are causing you discomfort, confusion, or concern, the right step is to speak to someone who can properly assess what is happening. That might be your GP as a first point of contact, or a menopause specialist if your symptoms are part of a broader picture.

The challenge many women face is that standard appointments in primary care do not always allow enough time to explore vaginal and urogenital symptoms in more detail. Particularly when these symptoms sit alongside other menopausal symptoms such as hot flushes, anxiety and brain fog, they often go undiscussed in shorter consultations.

Voy's menopause consultations are 45 minutes with BMS-trained specialists. That allows time to take a full symptom history, discuss your vaginal health specifically, review your options for vaginal oestrogen or other treatments, and address any concerns about safety or suitability. 88% of Voy members felt more hormonally balanced at three months, compared to 62% receiving standard care (presented at The Menopause Society 2025, forthcoming in Climacteric). And 93% reported an improvement in their overall quality of life after starting treatment.

You do not have to piece this together from search results. You deserve a proper conversation with someone who specialises in exactly this.